Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast age… Read more
Bayer Aktiengesellschaft (BAYA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.057x
Based on the latest financial reports, Bayer Aktiengesellschaft (BAYA) has a cash flow conversion efficiency ratio of 0.057x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.69 Billion) by net assets (€29.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bayer Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Bayer Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bayer Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bayer Aktiengesellschaft ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing-Shanghai High Speed Railway Co Ltd
SHG:601816
|
0.027x |
|
Nestle India Limited
NSE:NESTLEIND
|
0.522x |
|
Ningxia Baofeng Energy Group Co Ltd
SHG:600989
|
0.122x |
|
Jentech Precision Industrial Co Ltd
TW:3653
|
0.047x |
|
Hyundai Motor Company
F:HYU
|
0.019x |
|
ENN Energy Holdings Ltd
PINK:XNGSY
|
0.138x |
|
Donaldson Company Inc
NYSE:DCI
|
0.083x |
|
Builders FirstSource Inc
NYSE:BLDR
|
0.127x |
Annual Cash Flow Conversion Efficiency for Bayer Aktiengesellschaft (2016–2024)
The table below shows the annual cash flow conversion efficiency of Bayer Aktiengesellschaft from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €32.05 Billion | €7.37 Billion | 0.230x | +48.63% |
| 2023-12-31 | €33.08 Billion | €5.12 Billion | 0.155x | -15.10% |
| 2022-12-31 | €38.93 Billion | €7.09 Billion | 0.182x | +18.76% |
| 2021-12-31 | €33.17 Billion | €5.09 Billion | 0.153x | -3.93% |
| 2020-12-31 | €30.70 Billion | €4.90 Billion | 0.160x | -7.53% |
| 2019-12-31 | €47.52 Billion | €8.21 Billion | 0.173x | +0.68% |
| 2018-12-31 | €46.15 Billion | €7.92 Billion | 0.172x | -22.26% |
| 2017-12-31 | €36.86 Billion | €8.13 Billion | 0.221x | -22.56% |
| 2016-12-31 | €31.90 Billion | €9.09 Billion | 0.285x | -- |